期刊文献+

HIF-1α在骨髓增生异常综合征患者中表达水平及其与预后的关系 被引量:2

The expression of HIF-1α in myelodysplastic syndrome and its clinical prognostic value
下载PDF
导出
摘要 目的:探讨缺氧诱导因子-1α(HIF-1α)在骨髓增生异常综合征(MDS)患者中的表达水平及其与预后的关系。方法 :采用荧光定量PCR(qPCR)法检测48例MDS患者(MDS组)和20例健康捐献者(对照组)骨髓中HIF-1α mRNA的相对表达量,分析HIF-1α的表达与患者预后情况的关系。结果:MDS组HIF-1α mRNA相对表达量明显高于对照组(P<0.001)。23例难治性贫血伴原始细胞增多-1(RAEB1)/RAEB2 MDS患者HIF-1α mRNA相对表达量显著高于25例难治性贫血(RA)/难治性贫血伴环型铁粒幼红细胞增多(RARS)/难治性血细胞减少伴多系发育异常(RCMD)/5q-综合征(5q-)患者(P<0.05)。38例根据国际预后评分系统(IPSS)进行分组,其中18例IPSS≥1.5分患者HIF-1α mRNA相对表达量显著高于20例IPSS<1.5分患者(P<0.05),MDS患者HIF-1α mRNA相对表达量与IPSS预后评分呈正相关关系(r=0.54,P<0.001)。免疫荧光原位杂交(FISH)检测及染色体异常组患者HIF-1α mRNA相对表达量均显著高于正常组(均P<0.05),MDS患者HIF-1α mRNA表达水平与染色体核型预后呈正相关关系(r=0.62,P<0.001)。结论:HIF-1α在MDS患者中呈高表达,且与染色体核型异常有关,可能是MDS患者预后不良的因素之一。 Objective:To investigate the expression of hypoxia-inducible factor-1α(HIF-1α) in patients with myelodysplastic syndrome (MDS) and its clinical prognostic value. Methods.. The mRNA expression of HIF-1α in bone marrow from 48 MDS patients and 20 healthy donates were detected by qPCR, and the relationship between the expression of HIF-1α and the clinical characteristics was analyzed. Results: The mRNA expression of HIF-1 α in MDS patients was significantly higher than that in controls ( P 〈0. 001). The mRNA expression of HIF-1α in 23 cases with refractory anemia (RA) with excess blasts (RAEB) was obviously higher than 9.5 cases with RA, RA with ring sideroblasts (RARS), RA with multiple dysplasia (RCMD) and 5q syndrome ( P 〈0.05). According to International Prognostic Scoring System (IPSS) score, of 38 patients with MDS, the expression of HIF-1α mRNA was higher in 18 patients with IPSS score ≥1.5, compared to those with IPSS score 〈1.5 ( P 〈0.05). Spearman correlation analysis showed that the expression of HIF-1α in MDS patients was positively correlated with IPSS prognosis score ( r =0.54, P 〈0. 001). Fluorescence in situ hybridization (FISH) and chromosome karyotype analysis showed that the mRNA expression of HIF-1α in chromosomal-abnormal group was significantly higher than that in chromosome-normal group ( P 〈0.05). The mRNA expression of HIF-1α in MDS patients was positively correlated with chromosome karyotype prognosis ( r =-0.62, P 〈0. 001). Conclusion: High expression of HIF-1α mRNA in MDS patients was associated with chromosome karyotype abnormality, which may be one of the poor prognostic factors for MDS.
出处 《广西医科大学学报》 CAS 2017年第5期730-733,共4页 Journal of Guangxi Medical University
基金 广西医疗卫生适宜技术研究与开发课题资助项目(No.s201303-04)
关键词 骨髓增生异常综合征 缺氧诱导因子-1Α 临床预后 myelodysplastic syndromes hypoxia-inducible factor-1α clinical prognosis
  • 相关文献

参考文献2

二级参考文献12

  • 1Keith T, Araki Y,Ohyagi M,et al. Regulation of angiogenesis inthe bone marrow of myelodyspiastic syndromes transforming to o-vert leukaemia[J]. Br J Haematol,2007 ,137(3) : 206-215.
  • 2Vardiman JW,Thiele J, Arber DA,et al. The 2008 revision of theWorld Health Organization (WHO) classification of myeloid neo-plasms and acute leukemia: rationale and important changes[J].Blood,2009,114(5):937-951.
  • 3Malcovati L, Della Porta M G, Strupp C, et al. Impact of the de-gree of anemia on the outcome of patients with myelodyspiasticsyndrome and its integration into the WHO classification-basedPrognostic Scoring System (WPSS) [J], Haematologica, 2011, 96(10):1433-1440.
  • 4Tang N.Wang L’Esko J,et al. Loss of HIF-la in endothelial cellsdisrupts a hypoxia-driven VEGF autocrine loop necessary for tu-morigenesis[J]. Cancer Cell,2004,6(5) :485-495.
  • 5Ghosh AK, Shanafelt TD, Cimmino A, et al. Aberrant regulationof pVHL levels by microRNA promotes the HIF/VEGF axis inCLL B cells[J]. Blood,2009 ,113(22) : 5568-5574.
  • 6Wang Y, Liu Y, Malek S N* et al. Targeting HIFla eliminatescancer stem cells in hematological malignancies [J]. Cell StemCell,2011,8(4) :399-411.
  • 7Rosen MD. Venkatesan H,Peltier HM, et al. Benzimidazole-2-pyrazole HIF prolyl 4-hydroxylase inhibitors as oral erythropoie-tin secretagogues[J]. ACS Med Chem Lett,2010,1 (9) :526-529.
  • 8Bernhardt WM,Wiesener MS,Scigalla P,et al. Inhibition of prolylhydroxylases increases erythropoietin production in ESRD [ J].JASN,2010,21(12) :2151-2156.
  • 9Hsieh MM, Linde NS, Wynter A, et al. HIF-prolyl hydroxylaseinhibition results in endogenous erythropoietin induction,erythro-cytosis, and modest fetal hemoglobin expression in rhesus ma-caques[J]. Blood,2007,110(6) :2140-2147.
  • 10赵梅青,赵洪国,杜以萍.MDS病人血清血管内皮生长因子水平检测[J].青岛大学医学院学报,2008,44(1):72-74. 被引量:4

共引文献205

同被引文献16

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部